Work

Concurrent FLT3 Inhibitor and IDH Inhibitor Therapy in Patients with Acute Myeloid Leukemia (AML)

Year: 2020

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2020-140118

Authors: Amir T. Fathi, Alexander E. Perl, Mark Levis, Catherine C. Smith, Andrew M. Brunner, Koichi Takahashi, Philip C. Amrein, Hanno R. Hock, Gabriela S. Hobbs, Rupa Narayan, Jenna A. Moran, Meghan Bergeron, Julia E. Foster, Naval Daver, Courtney D. DiNardo

Institutions: Harvard University, Massachusetts General Hospital, University of Pennsylvania, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of California, San Francisco, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3094855182

FWCI: 0.817

Cites:

Cited by: 14

Related to: 10